# Alterity Therapeutics Ltd: Form 20-F for the period ended Jun 30, 2023

- Company: [Alterity Therapeutics Ltd](/companies/athe.md) (CIK 1131343)
- Form: 20-F
- Filed: 2023-08-31
- Accepted by EDGAR: Aug 31, 2023, 09:15 ET
- Period: 2023-06-30
- Accession: 0001213900-23-072629
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1131343/000121390023072629/f20f2023_alteritytherap.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1131343/000121390023072629/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2023-06-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Income tax | 12 months, 2022-07-01 to 2023-06-30 | AUD 104.5k | ifrs-full:IncomeTaxExpenseContinuingOperations |
| Net income | 12 months, 2022-07-01 to 2023-06-30 | AUD 13.8m | ifrs-full:ProfitLossAttributableToOwnersOfParent |
| Diluted EPS | 12 months, 2022-07-01 to 2023-06-30 | −AUD 0.57 | ifrs-full:DilutedEarningsLossPerShare |
| Basic EPS | 12 months, 2022-07-01 to 2023-06-30 | −AUD 0.57 | ifrs-full:BasicEarningsLossPerShare |
| Operating cash flow | 12 months, 2022-07-01 to 2023-06-30 | −AUD 20.0m | ifrs-full:CashFlowsFromUsedInOperatingActivities |
| Capital expenditure | 12 months, 2022-07-01 to 2023-06-30 | AUD 7.3k | ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities |
| Cash and equivalents | at 2023-06-30 | AUD 15.8m | ifrs-full:CashAndCashEquivalents |
| Current assets | at 2023-06-30 | AUD 27.0m | ifrs-full:CurrentAssets |
| Total assets | at 2023-06-30 | AUD 27.3m | ifrs-full:Assets |
| Current liabilities | at 2023-06-30 | AUD 4.4m | ifrs-full:CurrentLiabilities |
| Total liabilities | at 2023-06-30 | AUD 4.5m | ifrs-full:Liabilities |
| Shares outstanding | at 2023-06-30 | 2,439,897,618 shares | dei:EntityCommonStockSharesOutstanding |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1131343/000121390023072629/f20f2023_alteritytherap.htm

Filed Aug 31, 2023.
Source: SEC EDGAR, the filing index for accession 0001213900-23-072629. Last ingested by Listed: Oct 30, 2026, 06:15 ET. No prices; not investment advice.